SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001554795-21-000381
Filing Date
2021-11-05
Accepted
2021-11-05 15:16:40
Documents
29
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cncl1103form10q.htm   iXBRL 10-Q 247327
2 EXHIBIT 31.1 cncl1103form10qexh31_1.htm EX-31.1 8098
3 EXHIBIT 31.2 cncl1103form10qexh31_2.htm EX-31.2 8112
4 EXHIBIT 32.1 cncl1103form10qexh32_1.htm EX-32.1 4022
  Complete submission text file 0001554795-21-000381.txt   1134384

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cncl-20210930.xsd EX-101.SCH 8031
6 XBRL CALCULATION FILE cncl-20210930_cal.xml EX-101.CAL 18062
7 XBRL DEFINITION FILE cncl-20210930_def.xml EX-101.DEF 10359
8 XBRL LABEL FILE cncl-20210930_lab.xml EX-101.LAB 96679
9 XBRL PRESENTATION FILE cncl-20210930_pre.xml EX-101.PRE 69039
10 EXTRACTED XBRL INSTANCE DOCUMENT cncl1103form10q_htm.xml XML 71982
Mailing Address 2157 S. LINCOLN SUITE 200 SALT LAKE CITY UT 84106
Business Address 2157 S. LINCOLN SUITE 200 SALT LAKE CITY UT 84106 801-323-2395
CANCER CAPITAL CORP (Filer) CIK: 0001130889 (see all company filings)

IRS No.: 911803648 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-32363 | Film No.: 211384224
SIC: 6770 Blank Checks